A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library

Journal of Immunology

Volumn 169, Issue 5, 2002, Pages 2772-2780

  Somers, Veerle A ^a   Brandwijk, Ricardo J ^a   Joosten, Ben ^a   Moerkerk, Peter T ^a   Arends, Jan Willem ^a   Menheere, Paul ^a   Pieterse, Wendy O ^a   Claessen, Anke ^a   Scheper, Rik J ^a   Hoogenboom, Hennie R ^a   Hufton, Simon E ^a  

^a Dyax sa Building 22 ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COAT PROTEIN; HYBRID PROTEIN; PROTEIN PVI; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ADULT; AGED; ARTICLE; BACTERIOPHAGE; COLORECTAL CANCER; CONTROLLED STUDY; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SERODIAGNOSIS; VACCINATION;

EID: 0036721640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.5.2772     Document Type: Article

References (51)

1. Cell surface antigens of human renal cancer defined by autologous typing
2. Cancer immunology: The search for specificity: G. H. A. Clowes Memorial Lecture
3. Human tumor antigens recognized by T lymphocytes
4. Human neoplasms elicit multiple specific immune responses in the autologous host
5. Antigens recognized by autologous antibody in patients with renal-cell carcinoma
6. Characterization of human colon cancer antigens recognized by autologous antibodies
7. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes
8. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library
9. Serologic responses in patients with malignant mesothelioma: Evidence for both public and private specificities
10. Phage display of cDNA repertoires: The pVI display system and its applications for the selection of immunogenic ligands
11. Serological antigen selection of phage displayed colorectal tumour cDNA libraries
12. Natural and designer binding sites made by phage display technology
13. Phage antibodies: Filamentous phage displaying antibody variable domains
14. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies
15. Peptide and protein display on the surface of filamentous bacteriophage
16. Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library
17. Selection of biologically active peptides by phage display of random peptide libraries
18. Phage display of proteins
19. A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera
20. Display of biologically active proteins on the surface of filamentous phages: A cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production
21. Display of expression products of cDNA libraries on phage surfaces: A versatile screening system for selective isolation of genes by specific gene-product/ligand interaction
22. Surface expression and ligand-based selection of cDNAs fused to filamentous phage gene VI
23. Affinity selection of cDNA libraries by λ phage surface display
24. Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial
25. By-passing immunization: Human antibodies from V-gene libraries displayed on phage
26. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization
27. Induction of anti-self-immunity to cure cancer
28. Harnessing self-reactivity in cancer immunotherapy
29. Identification of genes overexpressed in tumors through preferential expression screening in trophoblasts
30. Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene
31. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
32. The S3a ribosomal protein gene is identical to the Fte-1 (v-fos transformation effector) gene and the TNF-α-induced TU-11 gene, and its transcript level is altered in transformed and tumor cells
33. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation
34. Serological identification of human tumor antigens
35. Cloning Aspergillus fumigatus allergens by the pJuFo filamentous phage display system
36. + T cell responses
37. + T cells recognize a peptide corresponding to a common mutation (13Gly→Asp)
38. + T-cell immunity to mutated ras protein in pancreatic and colon cancer patients
39. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
40. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
41. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
42. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens
43. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
44. T cell activation determined by T cell receptor number and tunable thresholds
45. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
46. Antibody to ras proteins in patients with colon cancer
47. A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction
48. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
49. Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals
50. Cancer-testis antigens: Targets for cancer immunotherapy
51. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma